Kyle Kline Biography and Net Worth

Senior Vice President and Chief Financial Officer of Globus Medical

Kyle Kline has served as our Senior Vice President and Chief Financial Officer since July 2025. Kyle previously served as our Senior Vice President of Finance and held roles of increasing responsibility in accounting and finance since joining the Company as Assistant Controller in May 2017. In his role as Senior Vice President of Finance, Kyle led the Company’s day-to-day accounting, finance, treasury, and tax functions. Kyle joined the Company after nearly 10 years at Deloitte & Touche, LLP, a multinational professional services network, in which he served in several leadership roles in Deloitte’s audit practice, most recently as Senior Manager. While at Deloitte, Kyle served both large multinational public companies and private equity-owned portfolio organizations, primarily in the life sciences and manufacturing industries. Kyle’s financial leadership experience includes financial planning and analysis, treasury, controllership, tax, and audit.

Kyle holds a Bachelor of Science in accounting from Bloomsburg University.

How do I contact Kyle Kline?: The corporate mailing address for Mr. Kline and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Kyle Kline's contact information.
Has Kyle Kline been buying or selling shares of Globus Medical?: Within the last three months, Kyle Kline has sold $1,668,780.00 in Globus Medical stock. Most recently, Kyle Kline sold 18,542 shares of the business's stock in a transaction on Monday, December 1st. The shares were sold at an average price of $90.00, for a transaction totalling $1,668,780.00. Learn More on Kyle Kline's trading history.
Who are Globus Medical's active insiders?: Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Kyle Kline (Senior Vice President and Chief Financial Officer), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), James Tobin (Director), and Stephen Zarrilli (Director). Learn More on Globus Medical's active insiders.
Are insiders buying or selling shares of Globus Medical?: During the last year, insiders at the medical device company sold shares 8 times. They sold a total of 110,209 shares worth more than $9,254,434.43. The most recent insider tranaction occured on December, 1st when CFO Kyle Kline sold 18,542 shares worth more than $1,668,780.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.
Information on this page was last updated on 12/1/2025.

Kyle Kline Insider Trading History at Globus Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/1/2025	Sell	18,542	$90.00	$1,668,780.00

Kyle Kline Buying and Selling Activity at Globus Medical

Globus Medical Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Today's Range

Now: $87.92

$87.61

$88.71

50 Day Range

MA: $81.22

$60.51

$91.12

2 Week Range

Now: $87.92

$51.79

$94.93

Volume

135,192 shs

Average Volume

1,480,744 shs

Market Capitalization

$11.77 billion

P/E Ratio

28.38

Dividend Yield

N/A

Beta

1.07